Canaccord lowered the firm’s price target on Docebo to $55 from $65 and keeps a Buy rating on the shares. The firm noted the shares fell on Q1 results ahead of expectations and with strong enterprise but a lacklustre 2024 revenue growth outlook. Canaccord said with the baseline for growth reset lower and the company clearly motivated to expand margins, Docebo appears well positioned to outpace expectations through the reminder of F2024.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DCBO: